Medimix International to Showcase Services and New Online Medical Community at ASCO AGM - May 30-June 1st
Medimix International, a leader in global healthcare marketing research for life sciences industry, announced today that it will be exhibiting at the 45th AGM of the American Society of Clinical Oncology in Orlando, Florida (May 29-June 2, 2009). With over 26,000 professionals from 128 countries attending the ASCO event, Medimix’s presence will have a dual purpose: to extend an invitation to these experts to become part of its new online community and to showcase its services.
Miami, FL, May 22, 2009 --(PR.com)-- Medimix International, a leader in global healthcare marketing research for life sciences industry, announced today that it will be exhibiting at the 45th AGM of the American Society of Clinical Oncology, which will take place in Orlando, Florida from May 29-June 2, 2009. The annual ASCO meeting is considered to be the premier educational and scientific event in the oncology community, a forum for cutting-edge scientific and educational developments in oncology with a focus on personalizing cancer care.
Medimix International has a long history of working in the field of oncology/hematology, one of its key therapeutic areas, and in fact around 35-40% of its yearly projects are conducted in that area. It currently manages a panel of more than 17,000 oncologists and over 13,000 hematologists from North America, Europe, Asia, Latin America, and the Middle East. Specialties included in the panel are medical, radiation, surgical, gynecology, and pediatric, with Medimix’s demonstrating particular expertise in the areas of anemia, breast, lung, bowel, prostate, and renal cancers.
“Oncology is a very challenging field where treatment options are continuously evolving,” commented Dr. Tessa Schoor, Medimix’s Chief Medical Officer. “It is crucial for us to stay up to date on the new therapeutic outcomes that are discussed at the ASCO meeting every year.”
With over 26,000 professionals from 128 countries attending the ASCO event, Medimix’s presence will have a dual purpose: to extend an invitation to these experts to become part of its new online community and to showcase its services to clients in the pharmaceutical, medical device and biotechnology fields.
“Over 53% of visitors at ASCO come from outside the United States,” noted Henry Gazay, CEO of Medimix. “The reach of our onco/hematology panel being global, exhibiting at ASCO represents a unique opportunity to meet some of the key members of our community from diverse countries around the world. Physicians and KOLs will come to our booth to share their experience of working with us and working together. It is also a great opportunity to show new marketing services to our clients.”
About Medimix International
Medimix International is a dynamic provider of advanced marketing research solutions for the healthcare industry worldwide. Medimix’s proprietary panel provides direct access to over 500,000 physicians and healthcare professionals from around the world, making it one of the largest panels in the industry.
Medimix specializes in global research. Learn more at www.medimix.net.
###
Medimix International has a long history of working in the field of oncology/hematology, one of its key therapeutic areas, and in fact around 35-40% of its yearly projects are conducted in that area. It currently manages a panel of more than 17,000 oncologists and over 13,000 hematologists from North America, Europe, Asia, Latin America, and the Middle East. Specialties included in the panel are medical, radiation, surgical, gynecology, and pediatric, with Medimix’s demonstrating particular expertise in the areas of anemia, breast, lung, bowel, prostate, and renal cancers.
“Oncology is a very challenging field where treatment options are continuously evolving,” commented Dr. Tessa Schoor, Medimix’s Chief Medical Officer. “It is crucial for us to stay up to date on the new therapeutic outcomes that are discussed at the ASCO meeting every year.”
With over 26,000 professionals from 128 countries attending the ASCO event, Medimix’s presence will have a dual purpose: to extend an invitation to these experts to become part of its new online community and to showcase its services to clients in the pharmaceutical, medical device and biotechnology fields.
“Over 53% of visitors at ASCO come from outside the United States,” noted Henry Gazay, CEO of Medimix. “The reach of our onco/hematology panel being global, exhibiting at ASCO represents a unique opportunity to meet some of the key members of our community from diverse countries around the world. Physicians and KOLs will come to our booth to share their experience of working with us and working together. It is also a great opportunity to show new marketing services to our clients.”
About Medimix International
Medimix International is a dynamic provider of advanced marketing research solutions for the healthcare industry worldwide. Medimix’s proprietary panel provides direct access to over 500,000 physicians and healthcare professionals from around the world, making it one of the largest panels in the industry.
Medimix specializes in global research. Learn more at www.medimix.net.
###
Contact
Medimix International
Kathryn McAdam
305-573-5233
www.medimix.net
Kathryn McAdam
305-573-5233
www.medimix.net
Contact
Categories